Linder Thomas is an experienced professional in the pharmaceutical and healthcare industries, currently serving as a Field Access and Reimbursement Manager for Biosimilars at Sandoz since March 2023, focusing on Hyrimoz (adalimumab). Previously, Linder held significant roles including National Account Director at Mycovia Pharmaceuticals, leading the launch of Vivjoa (oteseconazole), and National Strategic Account Director at Banner Life Sciences, managing the launch of Bafiertam (monomethyl fumarate). With a history at Amneal Biosciences as Director of Market Access and various positions at Bayer HealthCare, Linder has developed and managed strategic relationships across multiple levels of healthcare, including Managed Care Organizations and Specialty Pharmacies. Linder holds a B.S. in International Business from the University of South Alabama, completed an International Spanish Language Program in Cuernavaca, Mexico, and is currently pursuing certification as a Prior Authorization Certified Specialist.
This person is not in any teams
This person is not in any offices